• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜麦芽窄食单胞菌所致血流感染和肺炎患者的死亡相关因素。

Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia.

作者信息

Paez J I Garcia, Tengan F M, Barone A A, Levin A S, Costa S F

机构信息

Department of Infectious Diseases, Hospital das Clinicas, University of São Paulo Medical School, São Paulo, Brazil.

出版信息

Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):901-6. doi: 10.1007/s10096-008-0518-2. Epub 2008 May 16.

DOI:10.1007/s10096-008-0518-2
PMID:18483755
Abstract

Severe infections caused by Stenotrophomonas maltophilia are associated with high mortality, and strategies to improve the clinical outcome for infected patients are needed. A retrospective cohort study of patients with bloodstream infection (BSIs) and pneumonia caused by S. maltophilia was conducted. Multivariate analysis was performed to access factors associated with 14-day mortality. A total of 60 infections were identified. Among these, eight (13%) were pneumonias and 52 were BSIs; 33.3% were primary, 13% were central venous catheter (CVC)-related and 40% were secondary BSIs. Fifty-seven (85%) patients had received previous antimicrobial therapy; 88% had CVC, 57% mechanical ventilation and 75% were in the intensive care unit at the onset of infection. Malignancy (45%) was the most frequent underlying disease. The mean of the Acute Physiology and Chronic Health Evaluation II (APACHE II) scores was 17 and for the Sepsis-related Organ Failure Assessment (SOFA) score, it was 7 points. The overall and 14-day mortality were, respectively, 75% and 48%. Forty-seven (78%) patients were treated and, of these, 74% received trimethoprim-sulfamethoxazole. Independent risk factors associated with mortality were SOFA index >6 points (0.005) and septic shock (0.03). The Kaplan-Meier estimations curves showed that patients with APACHE II score >20 and SOFA score >10 had a survival chance of, respectively, less than 8% and less than 10% (P<or=0.001) at 21 days after the first positive S. maltophilia culture. Our results suggest that the independent factors associated with outcome in patients with infection caused by S. maltophilia are septic shock and higher SOFA index.

摘要

嗜麦芽窄食单胞菌引起的严重感染与高死亡率相关,因此需要采取策略来改善感染患者的临床结局。我们对嗜麦芽窄食单胞菌引起的血流感染(BSIs)和肺炎患者进行了一项回顾性队列研究。进行多变量分析以确定与14天死亡率相关的因素。共识别出60例感染病例。其中,8例(13%)为肺炎,52例为BSIs;33.3%为原发性,13%与中心静脉导管(CVC)相关,40%为继发性BSIs。57例(85%)患者此前接受过抗菌治疗;88%患者有CVC,57%患者接受机械通气,75%患者在感染发作时入住重症监护病房。恶性肿瘤(45%)是最常见的基础疾病。急性生理与慢性健康状况评估II(APACHE II)评分的平均值为17分,脓毒症相关器官功能衰竭评估(SOFA)评分为7分。总体死亡率和14天死亡率分别为75%和48%。47例(78%)患者接受了治疗,其中74%接受了复方新诺明治疗。与死亡率相关的独立危险因素为SOFA指数>6分(P=0.005)和感染性休克(P=0.03)。Kaplan-Meier估计曲线显示,APACHE II评分>20分且SOFA评分>10分的患者在嗜麦芽窄食单胞菌首次培养阳性后21天的生存机会分别低于8%和10%(P≤0.001)。我们的结果表明,与嗜麦芽窄食单胞菌感染患者预后相关的独立因素是感染性休克和较高的SOFA指数。

相似文献

1
Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia.嗜麦芽窄食单胞菌所致血流感染和肺炎患者的死亡相关因素。
Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):901-6. doi: 10.1007/s10096-008-0518-2. Epub 2008 May 16.
2
Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review.嗜麦芽窄食单胞菌引起的感染死亡率相关危险因素:一项系统综述
J Hosp Infect. 2008 Oct;70(2):101-8. doi: 10.1016/j.jhin.2008.05.020. Epub 2008 Jul 14.
3
Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients.嗜麦芽寡养单胞菌在呼吸重症监护病房患者的呼吸道中。
Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1419-28. doi: 10.1007/s10096-011-1459-8. Epub 2011 Nov 7.
4
Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.嗜麦芽寡养单胞菌引起的血流感染:一项为期七年的回顾性研究。
J Hosp Infect. 2012 Jun;81(2):114-8. doi: 10.1016/j.jhin.2012.02.008. Epub 2012 Apr 10.
5
Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia.嗜麦芽窄食单胞菌血症患者死亡的危险因素。
Medicine (Baltimore). 2016 Aug;95(31):e4375. doi: 10.1097/MD.0000000000004375.
6
Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.儿童嗜麦芽窄食单胞菌血症——一项为期10年的分析
J Microbiol Immunol Infect. 2006 Apr;39(2):144-9.
7
Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.甲氧苄啶-磺胺甲恶唑敏感与耐药嗜麦芽窄食单胞菌单菌血症患者的比较:一项10年回顾性研究。
J Microbiol Immunol Infect. 2016 Jun;49(3):378-86. doi: 10.1016/j.jmii.2014.06.005. Epub 2014 Jul 28.
8
Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections.嗜麦芽寡养单胞菌血流感染:社区获得性感染与医院获得性感染的比较。
J Microbiol Immunol Infect. 2014 Feb;47(1):28-35. doi: 10.1016/j.jmii.2012.08.014. Epub 2012 Oct 2.
9
Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.1997 - 2004年无传统感染危险因素的癌症患者嗜麦芽窄食单胞菌肺炎
Eur J Clin Microbiol Infect Dis. 2007 Jan;26(1):13-20. doi: 10.1007/s10096-006-0243-7.
10
Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.嗜麦芽窄食单胞菌血流感染在血液系统恶性肿瘤患者中的回顾性研究及抗菌药物联合的体外活性
BMC Infect Dis. 2015 Feb 18;15:69. doi: 10.1186/s12879-015-0801-7.

引用本文的文献

1
Prognostic Models for Mortality in Elderly Patients with Stenotrophomonas Maltophilia Bacteremia.嗜麦芽窄食单胞菌血症老年患者死亡率的预后模型
Acta Inform Med. 2025;33(2):140-145. doi: 10.5455/aim.2025.33.140-145.
2
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature Review.头孢地尔治疗嗜麦芽窄食单胞菌引起的医院血流感染:病例系列及文献综述
Infect Dis Ther. 2025 Mar;14(3):657-669. doi: 10.1007/s40121-025-01117-2. Epub 2025 Mar 4.
3
Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014-2021.

本文引用的文献

1
Antimicrobial therapy for Stenotrophomonas maltophilia infections.嗜麦芽窄食单胞菌感染的抗菌治疗。
Eur J Clin Microbiol Infect Dis. 2007 Apr;26(4):229-37. doi: 10.1007/s10096-007-0279-3.
2
Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.1997 - 2004年无传统感染危险因素的癌症患者嗜麦芽窄食单胞菌肺炎
Eur J Clin Microbiol Infect Dis. 2007 Jan;26(1):13-20. doi: 10.1007/s10096-006-0243-7.
3
Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome.
2014 - 2021年中国嗜麦芽窄食单胞菌的流行病学及抗菌药物耐药性
Infect Dis Ther. 2025 Jan;14(1):261-274. doi: 10.1007/s40121-024-01099-7. Epub 2024 Dec 28.
4
Bacteremia: From Diagnosis to Treatment.菌血症:从诊断到治疗
Infect Dis Clin Microbiol. 2022 Dec 21;4(4):258-267. doi: 10.36519/idcm.2022.187. eCollection 2022 Dec.
5
Comparisons of the Oral Microbiota from Seven Species of Wild Venomous Snakes in Taiwan Using the High-Throughput Amplicon Sequencing of the Full-Length 16S rRNA Gene.利用全长16S rRNA基因的高通量扩增子测序对台湾七种野生毒蛇口腔微生物群进行比较
Biology (Basel). 2023 Sep 4;12(9):1206. doi: 10.3390/biology12091206.
6
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group.异基因造血干细胞移植后嗜麦芽窄食单胞菌感染的危险因素和结局:JSTCT,移植并发症工作组。
Ann Hematol. 2023 Sep;102(9):2507-2516. doi: 10.1007/s00277-023-05320-4. Epub 2023 Jun 20.
7
Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic Options.感染:现有治疗方法比较疗效的系统评价与荟萃分析,以及对新型治疗选择的批判性评估。
Antibiotics (Basel). 2023 May 15;12(5):910. doi: 10.3390/antibiotics12050910.
8
Upraising in Critically Ill Patients: A New Enemy?危重症患者的抬高:一个新的敌人?
Diagnostics (Basel). 2023 Mar 15;13(6):1106. doi: 10.3390/diagnostics13061106.
9
, a Pathogen of Increasing Relevance to Dermatologists: A Case Report and Review of the Literature.一种对皮肤科医生而言相关性日益增加的病原体:病例报告及文献综述
Antibiotics (Basel). 2022 Oct 12;11(10):1398. doi: 10.3390/antibiotics11101398.
10
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature.头孢他啶/阿维巴坦用于治疗COVID-19患者中由难治疗的非发酵革兰氏阴性菌引起的呼吸机相关性肺炎:病例系列及文献综述
Antibiotics (Basel). 2022 Jul 26;11(8):1007. doi: 10.3390/antibiotics11081007.
重症监护病房获得性嗜麦芽窄食单胞菌感染:发病率、危险因素及转归
Crit Care. 2006;10(5):R143. doi: 10.1186/cc5063.
4
Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients.癌症患者的中心静脉导管与嗜麦芽窄食单胞菌血症
Cancer. 2006 May 1;106(9):1967-73. doi: 10.1002/cncr.21846.
5
[Epidemiology, clinical features and prognosis of infections due to Stenotrophomonas maltophilia].[嗜麦芽窄食单胞菌感染的流行病学、临床特征及预后]
Enferm Infecc Microbiol Clin. 2006 Jan;24(1):4-9. doi: 10.1157/13083367.
6
Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia.嗜麦芽窄食单胞菌引起的血流感染患者初始抗菌治疗的影响
Antimicrob Agents Chemother. 2005 Sep;49(9):3980-1. doi: 10.1128/AAC.49.9.3980-3981.2005.
7
Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan.成人嗜麦芽窄食单胞菌血症:台湾北部一家医疗中心的四年经验
J Microbiol Immunol Infect. 2004 Dec;37(6):359-65.
8
Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.嗜麦芽窄食单胞菌血症患者的临床特征及预后因素
J Microbiol Immunol Infect. 2004 Dec;37(6):350-8.
9
Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes.嗜麦芽窄食单胞菌所致菌血症:45例病例分析
J Infect. 2002 Jul;45(1):47-53. doi: 10.1053/jinf.2002.0978.
10
Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients.重症创伤患者中嗜麦芽窄食单胞菌引起的迟发性医院获得性肺炎的危险因素。
Clin Infect Dis. 2002 Aug 1;35(3):228-35. doi: 10.1086/341022. Epub 2002 Jul 2.